Clinicopathological significance of angiopoietin-like protein 4 expression in oesophageal squamous cell carcinoma

Journal of Clinical Pathology

Volumn 63, Issue 12, 2010, Pages 1054-1058

  Shibata, Kenichiro ^a   Nakayama, Toshiyuki ^a   Hirakawa, Hiroshi ^a   Hidaka, Shigekazu ^a   Nagayasu, Takeshi ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN; ANGIOPOIETIN LIKE PROTEIN 4; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER INVASION; CLINICAL FEATURE; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS MUCOSA; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL RATE; TUMOR DIFFERENTIATION; TUMOR EMBOLISM;

AGED; ANGIOPOIETINS; BLOOD VESSELS; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; ESOPHAGUS; FEMALE; HUMANS; MALE; MIDDLE AGED; MUCOUS MEMBRANE; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NEOPLASTIC CELLS, CIRCULATING; PROGNOSIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 78649633710     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jcp.2010.078600     Document Type: Article

References (25)

1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
2. Xiao ZF, Yang ZY, Liang J, et al. Value of radiotherapy after radical surgery for esophageal carcinoma: a report of 495 patients. Ann Thorac Surg 2003;75:331-6.
3. Mariette C, Balon JM, Piessen G, et al. Pattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent disease. Cancer 2003;97:1616-23.
4. Kimura H, Konishi K, Arakawa H, et al. Number of lymph node metastases influences survival in patients with thoracic esophageal carcinoma:therapeutic value of radiation treatment for recurrence. Dis Esophagus 1999;12:205-8.
5. Yu X, Burgess SC, Ge H, et al. Inhibition of cardiac lipoprotein utilization by transgenic overexpression of Angptl4 in the heart. Proc Natl Acad Sci USA 2005;102:1767-72.
6. Mandard S, Zandbergen F, van Straten E, et al. The fasting-induced adipose factor/angiopoietin-like protein 4 is physically associated with lipoproteins and governs plasma lipid levels and adiposity. J Biol Chem 2006;281:934-44.
7. Romeo S, Pennacchio LA, Fu Y, et al. Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL. Nat Genet 2007;39:513-16.
8. Yin W, Romeo S, Chang S, et al. Genetic variation in ANGPTL4 provides insights into protein processing and function. J Biol Chem 2009;284:13213-22.
9. Romeo S, Yin W, Kozlitina J, et al. Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans. J Clin Invest 2009;119:70-9.
10. Hato T, Tabata M, Oike Y, et al. The role of angiopoietin-like proteins in angiogenesis and metabolism. Trends Cardiovasc Med 2008;18:6-14.
11. Kim I, Kim HG, Kim H, et al. Hepatic expression, synthesis and secretion of a novel fibrinogen/angiopoietin-related protein that prevents endothelial-cell apoptosis. Biochem J 2000;346:603-10.
12. Le Jan S, Amy C, Cazes A, et al. Angiopoietin-like 4 is a proangiogenic factor produced during ischemia and in conventional renal cell carcinoma. Am J Pathol 2003;162:1521-8.
13. Galaup A, Cazes A, Le Jan S, et al. Angiopoietin-like 4 prevents metastasis through inhibition of vascular permeability and tumor cell motility and invasiveness. Proc Natl Acad Sci USA 2006;103:18721-6.
14. Li KQ, Li WL, Peng SY, et al. Anti-tumor effect of recombinant retroviral vector-mediated human ANGPTL4 gene transfection. Chin Med J (Engl) 2004;117:1364-9.
15. Ifon ET, Pang AL, Johnson W, et al. U94 alters FN1 and ANGPTL4 gene expression and inhibits tumorigenesis of prostate cancer cell line PC3. Cancer Cell Int 2005;5:19.
16. Nakayama T, Hirakawa H, Shibata K, et al. Expression of angiopoietin-like 4 in human gastric cancer: ANGPTL4 promotes venous invasion. Oncol Rep 2010;24:599-606.
17. Girroir EE, Hollingshead HE, Billin AN, et al. Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) ligands inhibit growth of UACC903 and MCF7 human cancer cell lines. Toxicolgy 2008;243:236-43.
18. Padua D, Zhang XH, Wang Q, et al. TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4. Cell 2008;133:66-77.
19. Sobin LH, Wittekind CH, eds. International Union Against Cancer. TNM Classification of Malignant Tumours. 6th edn. New York: John Wiley & Sons, Inc., 2002.
20. Gabbert HE, Shimoda T, Hainaut P, et al. Tumours of the oesophagus. In: Hamilton SR, Asltonen LA, eds. World Health Organization Classification of Tumours. Pathology & Genetics. Tumours of the Digestive System. Lyon: IARC Press, 2000:9-30.
21. Kersten S. Regulation of lipid metabolism via angiopoietin-like proteins. Biochem Soc Trans 2005;33:1059-62.
22. Li C. Genetics and regulation of angiopoietin-like proteins 3 and 4. Curr Opin Lipidol 2006;17:152-6.
23. Morisada T, Kubota Y, Urano T, et al. Angiopoietins and angiopoietin-like proteins in angiogenesis. Endothelium 2006;13:71-9.
24. Crissman JD, Hatfield JS, Menter DG, et al. Morphological study of the interaction of intravascular tumor cells with endothelial cells and subendothelial matrix. Cancer Res 1988;48:4065-72.
25. Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell 2002;110:673-87.